BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26732884)

  • 1. Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection.
    Ma WL; Hou HA; Hsu YJ; Chen YK; Tang JL; Tsay W; Yeh PT; Yang CM; Lin CP; Tien HF
    Ann Hematol; 2016 Mar; 95(4):593-601. PubMed ID: 26732884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma.
    Akiyama H; Takase H; Kubo F; Miki T; Yamamoto M; Tomita M; Mochizuki M; Miura O; Arai A
    Cancer Sci; 2016 Oct; 107(10):1458-1464. PubMed ID: 27412324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of intravitreal methotrexate for vitreo-retinal lymphoma - 20 years of experience.
    Habot-Wilner Z; Frenkel S; Pe'er J
    Br J Haematol; 2021 Jul; 194(1):92-100. PubMed ID: 33900619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic vitrectomy for vitreal recurrence of intraocular lymphoma resistant to intravitreal methotrexate post systemic chemotherapy.
    Venkatesh P; Gogia V; Khanduja S; Gupta S; Kumar L; Garg S
    J Cancer Res Ther; 2015; 11(3):668. PubMed ID: 26458712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
    Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
    Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of primary intraocular lymphoma: fine needle aspiration diagnosis and intravitreal methotrexate treatment.
    Zhao T; Li Y; Tang L; Wei X; Zhu X
    J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):142-144. PubMed ID: 21336740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis, treatment, and prognosis of primary intraocular lymphoma: Single-center real-world clinical experience.
    Min GJ; Kim TY; Jeon YW; O JH; Choi BO; Park G; Park YH; Cho SG
    Cancer Med; 2023 Apr; 12(7):7911-7922. PubMed ID: 36721307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of intravitreal methotrexate to salvage eyes with relapsed primary intraocular lymphoma.
    Mohammad M; Andrews RM; Plowman PN; Hay G; Arora AK; Cohen VML; Sagoo MS
    Br J Ophthalmol; 2022 Jan; 106(1):135-140. PubMed ID: 33087316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined intravitreal methotrexate and immunochemotherapy followed by reduced-dose whole-brain radiotherapy for newly diagnosed B-cell primary intraocular lymphoma.
    Kaburaki T; Taoka K; Matsuda J; Yamashita H; Matsuda I; Tsuji H; Tanaka R; Nakazaki K; Nakamura F; Kamiya K; Kurokawa M; Ohtomo K; Aihara M
    Br J Haematol; 2017 Oct; 179(2):246-255. PubMed ID: 28699673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of chitosan and polylactic acid based methotrexate intravitreal micro-implants to treat primary intraocular lymphoma: an in vitro study.
    Manna S; Augsburger JJ; Correa ZM; Landero JA; Banerjee RK
    J Biomech Eng; 2014 Feb; 136(2):021018. PubMed ID: 24317155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of intraocular lymphoma having retinal adverse events associated with intravitreal methotrexate].
    Kuroiwa N; Abematsu N; Matsuo Y; Nakao K; Sakamoto T
    Nippon Ganka Gakkai Zasshi; 2011 Jul; 115(7):611-6. PubMed ID: 21815491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary intraocular lymphoma.
    Sagoo MS; Mehta H; Swampillai AJ; Cohen VM; Amin SZ; Plowman PN; Lightman S
    Surv Ophthalmol; 2014; 59(5):503-16. PubMed ID: 24560125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients.
    Zhou X; Zhou X; Shi H; Lai J; Wang Q; Li Y; Chen K; Li Q; Zhou Q; Cao X; Chen B; Xiao J
    BMC Ophthalmol; 2020 May; 20(1):189. PubMed ID: 32397978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
    Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
    Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse.
    Klimova A; Heissigerova J; Rihova E; Brichova M; Pytlik R; Spicka I; Mrazova K; Karolova J; Svozilkova P
    Br J Ophthalmol; 2018 Nov; 102(11):1579-1585. PubMed ID: 29378728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous high-dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study.
    Lam M; Touitou V; Choquet S; Cassoux N; Ghesquières H; Kodjikian L; Schmitt A; Gattoussi S; Tabouret É; Sampo M; Blonski M; Angioi-Duprez K; Houot R; Mouriaux F; Gyan E; Le Lez ML; Moles MP; Croisé F; Chauchet A; Schwartz C; Ahle G; Meyer L; Gressin R; Chiquet C; Oberic L; Ollé P; Marolleau JP; Jany B; Tempescul A; Cochener B; Damaj G; Quintyn JC; Moluçon-Chabrot C; Rousseau E; Franciane P; Schneider C; Massé H; Tamburini-Bonnefoy J; Brézin A; Fornecker LM; Ballonzoli L; Le Garff-Tavernier M; Hoang-Xuan K; Bodaghi B; Soussain C; Houillier C
    Am J Hematol; 2021 Jul; 96(7):823-833. PubMed ID: 33864703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary intraocular lymphoma--2.5 year follow-up].
    Cholewa M; Chosia M; Jarema A; Lubiński W
    Klin Oczna; 2013; 115(3):234-7. PubMed ID: 24741931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary intraocular lymphoma invaded to the central nervous system after successful treatment with intraocular methotrexate injection].
    Watanabe K; Arai A; Takase H; Takahashi H; Iwanaga Y; Sugamoto Y; Sugita S; Mochizuki M; Miura O
    Rinsho Ketsueki; 2009 Mar; 50(3):182-6. PubMed ID: 19352085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Asian patient with intraocular lymphoma treated by intravitreal methotrexate.
    Wang JK; Yang CM; Lin CP; Shan YD; Lo AY; Tien HF
    Jpn J Ophthalmol; 2006; 50(5):474-478. PubMed ID: 17013703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.
    Akpek EK; Ahmed I; Hochberg FH; Soheilian M; Dryja TP; Jakobiec FA; Foster CS
    Ophthalmology; 1999 Sep; 106(9):1805-10. PubMed ID: 10485554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.